STEVEN SOCKIN, M.D.
Allergy & Immunology Physician in NEW CITY, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
STEVEN SOCKIN, M.D. filed 228 Medicare Part D claims in 2023 as a Allergy & Immunology Physician in NEW CITY, New York, prescribing 61% generic.
- 228
- Part D claims, 2023
- 61%
- generic prescribing
- $16.75
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
STEVEN SOCKIN, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
228 49th percentile higher than 49% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
STEVEN SOCKIN, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about STEVEN SOCKIN, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in New York
How Allergy & Immunology Physician compares to other specialties among New York providers
Allergy & Immunology Physician share within New York
Allergy & Immunology Physician is one of the more visible NUCC categories in New York
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Allergy & Immunology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Allergy & Immunology Physician ABMS/AOA estimate
Est. board-certified rate (Allergy & Immunology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Allergy & Immunology Physician US NPIs
Specialty board-certified rate — Allergy & Immunology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
STEVEN SOCKIN, M.D. appears in the CMS NPPES registry as a Allergy & Immunology Physician provider holding M.D. credentials at 500 NEW HEMPSTEAD RD, NEW CITY, NY, 10956, with a listed phone of (845) 362-3222. NPI 1750482394 was issued on 09/26/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SOCKIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 228 prescription claims written by this provider, covering 51 Medicare beneficiaries and totaling roughly $69K in drug spend, split 39% brand-name and 61% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Allergy & Immunology Physician is a narrow specialty nationwide, with 3,390 enrolled providers across 52 states and an average of 764 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1750482394 |
|---|---|
| Specialty | Allergy & Immunology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 09/26/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm STEVEN SOCKIN, M.D.'s current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for STEVEN SOCKIN, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$17
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — New York NYSBPMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to STEVEN SOCKIN, M.D.. To verify STEVEN SOCKIN, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
39% brand-name claims vs 61% generic, on 228 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 275
- Total Day Supply
- 7,733
- Brand vs Generic
- 39% brand / 61% generic
- Brand Drug Cost
- $64K
- Generic Drug Cost
- $5K
Patient Demographics
- Average Patient Age
- 68.4 years
- Avg HCC Risk Score
- 0.72
- Gender Split
- 55% female / 45% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What STEVEN SOCKIN, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Fluticasone Propio…
Fluticasone Propionate
50 claims
- Azelastine Hcl
Azelastine Hcl
42 claims
- Montelukast Sodium
Montelukast Sodium
26 claims
- Epinephrine
Epinephrine
25 claims
- Flovent Hfa 19
Flovent Hfa
19 claims
- Mometasone Furoate 16
Mometasone Furoate
16 claims
- Albuterol Sulfate … 15
Albuterol Sulfate Hfa
15 claims
- Dupixent Pen 13
Dupixent Pen
13 claims
| Drug | Claims |
|---|---|
| Fluticasone Propionate | 50 |
| Azelastine Hcl | 42 |
| Montelukast Sodium | 26 |
| Epinephrine | 25 |
| Flovent Hfa Fluticasone Propionate | 19 |
| Mometasone Furoate | 16 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 15 |
| Dupixent Pen Dupilumab | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Allergy & Immunology Physician Overview
How STEVEN SOCKIN, M.D. fits within the Allergy & Immunology Physician landscape nationally.
STEVEN SOCKIN, M.D.'s 228 claims are below the specialty average of 764.
Nearby Allergy & Immunology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as SOCKIN.
Compare Allergy & Immunology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is STEVEN SOCKIN, M.D.'s specialty? ▼
How much does STEVEN SOCKIN, M.D. prescribe under Medicare Part D? ▼
Where is STEVEN SOCKIN, M.D. located? ▼
What is STEVEN SOCKIN, M.D.'s NPI number? ▼
Does STEVEN SOCKIN, M.D. prescribe more brand-name or generic drugs? ▼
How many Allergy & Immunology Physician providers are there in the US? ▼
What drugs does STEVEN SOCKIN, M.D. prescribe most often? ▼
Does STEVEN SOCKIN, M.D. accept Medicare? ▼
How can I verify STEVEN SOCKIN, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology